Total Payments
$3,564
2024 Payments
$1,278
Companies
25
Transactions
156
Medicare Patients
10,252
Medicare Billing
$608,162
Payment Breakdown by Category
Food & Beverage$3,366 (94.4%)
Education$198.00 (5.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,366 | 154 | 94.4% |
| Education | $198.00 | 2 | 5.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $660.03 | 50 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $433.72 | 14 | $0 (2024) |
| PFIZER INC. | $333.96 | 19 | $0 (2024) |
| Medtronic, Inc. | $254.79 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $239.50 | 4 | $0 (2019) |
| Boston Scientific Corporation | $229.45 | 3 | $0 (2022) |
| ABIOMED | $192.14 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $149.40 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $130.75 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $123.06 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,278 | 52 | Alnylam Pharmaceuticals Inc. ($353.80) |
| 2023 | $857.96 | 45 | Novartis Pharmaceuticals Corporation ($320.65) |
| 2022 | $706.82 | 29 | Boston Scientific Corporation ($215.14) |
| 2021 | $278.46 | 14 | Novartis Pharmaceuticals Corporation ($80.12) |
| 2020 | $102.80 | 5 | AstraZeneca Pharmaceuticals LP ($44.12) |
| 2019 | $252.38 | 5 | Astellas Pharma US Inc ($239.50) |
| 2018 | $42.03 | 3 | Lundbeck LLC ($17.25) |
| 2017 | $46.04 | 3 | Janssen Pharmaceuticals, Inc ($30.98) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/14/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $173.01 | General |
| Category: Implant Cardio Defib - ICDs | ||||||
| 12/11/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: Genetic Disease | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.68 | General |
| Category: Cardiovascular | ||||||
| 11/19/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Ablation | ||||||
| 11/07/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: Genetic Disease | ||||||
| 10/30/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | LANTHEUS MEDICAL IMAGING, INC. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: CONTRAST AGENT | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.46 | General |
| Category: Cardiovascular | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Genetic Disease | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Rare Disease | ||||||
| 08/28/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $33.29 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/23/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Heart Failure | ||||||
| 08/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Genetic Disease | ||||||
| 08/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/31/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,968 | 2,313 | $386,889 | $139,562 |
| 2022 | 21 | 2,731 | 3,194 | $454,152 | $153,541 |
| 2021 | 20 | 2,348 | 2,633 | $445,346 | $154,727 |
| 2020 | 20 | 3,205 | 3,688 | $454,511 | $160,333 |
Total Patients
10,252
Total Services
11,828
Medicare Billing
$608,162
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 815 | 839 | $111,230 | $39,757 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 205 | 341 | $76,185 | $28,446 | 37.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 333 | 335 | $52,221 | $17,733 | 34.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 72 | 167 | $34,616 | $14,819 | 42.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 19 | 38 | $19,216 | $6,037 | 31.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 61 | 67 | $16,606 | $5,325 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 76 | $10,946 | $4,426 | 40.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 34 | $13,505 | $4,307 | 31.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 41 | $11,433 | $3,766 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $9,602 | $3,290 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 54 | $7,887 | $3,108 | 39.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 97 | 115 | $6,115 | $1,972 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 14 | $4,181 | $1,836 | 43.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 20 | $3,882 | $1,707 | 44.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 16 | 16 | $4,104 | $1,291 | 31.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 12 | 12 | $1,985 | $686.15 | 34.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 56 | 59 | $1,121 | $351.47 | 31.4% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 15 | 15 | $855.00 | $243.03 | 28.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 15 | 15 | $663.56 | $238.33 | 35.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 16 | 16 | $474.10 | $167.92 | 35.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $60.00 | $52.92 | 88.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 867 | 902 | $126,207 | $45,031 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 217 | 361 | $82,669 | $29,189 | 35.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 386 | 392 | $65,203 | $22,242 | 34.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 67 | 137 | $30,962 | $9,935 | 32.1% |
About Dr. Patrick Stevens, M.D
Dr. Patrick Stevens, M.D is a Cardiovascular Disease healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2011. The National Provider Identifier (NPI) number assigned to this provider is 1699065631.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Stevens, M.D has received a total of $3,564 in payments from pharmaceutical and medical device companies, with $1,278 received in 2024. These payments were reported across 156 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,366).
As a Medicare-enrolled provider, Stevens has provided services to 10,252 Medicare beneficiaries, totaling 11,828 services with total Medicare billing of $608,162. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Chattanooga, TN
- Active Since 04/11/2011
- Last Updated 07/21/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1699065631
Products in Payments
- AMVUTTRA (Drug) $433.72
- LEQVIO (Drug) $348.38
- ENTRESTO (Drug) $311.65
- VYNDAQEL (Drug) $267.44
- WATCHMAN Access System (Device) $215.14
- Impella (Device) $192.14
- AURORA EV-ICD MRI SURESCAN (Device) $173.01
- JARDIANCE (Drug) $149.40
- XARELTO (Drug) $123.06
- ELIQUIS (Drug) $95.26
- DEFINITY (Drug) $87.48
- VERQUVO (Drug) $84.59
- CAMZYOS (Drug) $83.14
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $69.84
- INJECTAFER (Drug) $68.92
- MICRA (Device) $65.38
- FARXIGA (Drug) $63.98
- Barostim Neo System (Device) $59.82
- PASCAL (Device) $44.71
- Arcalyst (Drug) $42.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Chattanooga
Dr. Harish Manyam, Md, MD
Cardiovascular Disease — Payments: $355,956
Cardiovascular Disease $355,956
William Blalock, Md, MD
Cardiovascular Disease — Payments: $59,707
Cardiovascular Disease $59,707
Newton Wiggins
Cardiovascular Disease — Payments: $48,698
Cardiovascular Disease $48,698
Dr. Michael Allan, Md, MD
Cardiovascular Disease — Payments: $33,290
Cardiovascular Disease $33,290
Dr. John Golding, Md, MD
Cardiovascular Disease — Payments: $26,247
Cardiovascular Disease $26,247
Walter Few, Md, MD
Cardiovascular Disease — Payments: $24,192
Cardiovascular Disease $24,192